Eventide Asset Management »

Dianthus Therapeutics shares owned by Eventide Asset Management

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Eventide Asset Management from 13F filings

Historical chart of Eventide Asset Management investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Eventide Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $19M 225k 83.92

More positions owned by Eventide Asset Management

Guardant Health (GH)
Trane Technologies SHS (TT)
Lam Research Corp Com New (LRCX)
Mirum Pharmaceuticals (MIRM)
Targa Res Corp (TRGP)
Xometry Class A Com (XMTR)
Ge Vernova (GEV)
Old Dominion Freight Line (ODFL)
Scholar Rock Hldg Corp (SRRK)
Argenx Se Sponsored Adr (ARGX)
Asml Hldg Nv N Y Registry Shs (ASML)
Irhythm Technologies (IRTC)
Insmed Com Par $.01 (INSM)
Axsome Therapeutics (AXSM)
Vaxcyte (PCVX)

View all positions for Eventide Asset Management

Top funds holding Dianthus Therapeutics

FMR
BlackRock
RA Capital Management
Wellington Management Company
Fairmount Funds Management
Avidity Partners Management
Vanguard Capital Management
Octagon Capital Advisors
TCG Crossover Management
Citadel Advisors
State Street Corporation
VR Adviser
Fred Alger Management
Polar Capital Holdings
Deerfield Management Company

View all funds holding Dianthus Therapeutics